Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Contraception and Contraceptive Drugs

  Free Subscription

Articles published in Obstet Gynecol

Retrieve available abstracts of 76 articles:
HTML format

Single Articles

    May 2023
  1. QURESHEY EJ, Ibarra CJ, Wagner SM, Chen HY, et al
    Effect of a Multimedia Educational Tool on Contraception Use 1 Year Postpartum.
    Obstet Gynecol. 2023 May 4. doi: 10.1097/AOG.0000000000005198.
    PubMed     Abstract available

  2. ARORA KS, Chua A, Miller E, Boozer M, et al
    Medicaid and Fulfillment of Postpartum Permanent Contraception Requests.
    Obstet Gynecol. 2023;141:918-925.
    PubMed     Abstract available

  3. NEBLETT MF 2ND, Stewart EA
    Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
    Obstet Gynecol. 2023;141:901-910.
    PubMed     Abstract available

    April 2023
  4. PEARLMAN SHAPIRO M, Myo M, Chen T, Nathan A, et al
    Remote Provision of Medication Abortion and Contraception Through Telemedicine.
    Obstet Gynecol. 2023 Apr 13. doi: 10.1097/AOG.0000000000005205.
    PubMed     Abstract available

  5. CREININ MD, Jensen JT, Chen MJ, Black A, et al
    Combined Oral Contraceptive Adherence and Pregnancy Rates.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005155.
    PubMed     Abstract available

  6. CREININ MD, Barnhart KT, Gawron LM, Eisenberg D, et al
    Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005137.
    PubMed     Abstract available

  7. CHEN BA, Kimble T, Harris LH, Kerns JL, et al
    Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005147.
    PubMed     Abstract available

  8. SUZUKI Y, Chen L, Hou JY, St Clair CM, et al
    Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005124.
    PubMed     Abstract available

  9. Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5.
    Obstet Gynecol. 2023;141:866-872.
    PubMed     Abstract available

    March 2023
  10. SCHWARTZ BI, Bear B, Short VL, Kazak AE, et al
    Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005123.
    PubMed     Abstract available

    February 2023
  11. MADISON AM, Powers D, Maslowsky J, Goyal V, et al
    Association Between Publicly Funded Contraceptive Services and the Abortion Rate in Texas, 2010-2015.
    Obstet Gynecol. 2023;141:361-370.
    PubMed     Abstract available

    January 2023
  12. PEARLMAN SHAPIRO M, Dethier D, Kahili-Heede M, Kaneshiro B, et al
    No-Test Medication Abortion: A Systematic Review.
    Obstet Gynecol. 2023;141:23-34.
    PubMed     Abstract available

    December 2022
  13. WU J, Trahair E, Happ M, Swartz J, et al
    TikTok, #IUD, and User Experience With Intrauterine Devices Reported on Social Media.
    Obstet Gynecol. 2022 Dec 6. doi: 10.1097/AOG.0000000000005027.
    PubMed     Abstract available

    November 2022
  14. UWANAKA O, Qureshey E, Wagner SM, Gupta M, et al
    Temporal Changes in Counseling for and Use of Emergency Contraception.
    Obstet Gynecol. 2022 Nov 3. pii: 00006250-990000000-00611.
    PubMed     Abstract available

  15. ANTHONY MS, Zhou X, Schoendorf J, Reed SD, et al
    Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion.
    Obstet Gynecol. 2022 Nov 3. pii: 00006250-990000000-00606.
    PubMed     Abstract available

    October 2022
  16. BAKER CC, Creinin MD
    Long-Acting Reversible Contraception.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00599.
    PubMed     Abstract available

  17. COLEMAN-MINAHAN K, Boniface ER, Fuentes-Rivera E, Saavedra-Avendano B, et al
    Patterns in Contraceptive Use Among Women of Mexican Origin in the United States and in Mexico.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00582.
    PubMed     Abstract available

  18. ROMANSKI PA, Gelvin B, Bortoletto P, Rosenwaks Z, et al
    Live-Birth Outcomes Among Women With Infertility and Anti-Mullerian Hormone Levels of 0.3 ng/mL or Lower.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00590.
    PubMed     Abstract available

  19. PANKO TL
    Reproductive Justice for the Deaf Community.
    Obstet Gynecol. 2022;140:560-564.
    PubMed     Abstract available

    September 2022

  20. General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3.
    Obstet Gynecol. 2022;140:528-541.
    PubMed     Abstract available

  21. CIRUCCI C, Harrison D, Francis C
    Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Obstet Gynecol. 2022;140:519.

  22. COCKRUM RH, Soo J, Ham SA, Cohen KS, et al
    Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
    Obstet Gynecol. 2022;140:477-487.
    PubMed     Abstract available

    August 2022
  23. ELGEMARK K, Graner S, McTaggart J, Ramirez Lofstrom J, et al
    The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy.
    Obstet Gynecol. 2022;140:227-233.
    PubMed     Abstract available

    July 2022
  24. MARTINEZ OP, Wilder L, Seal P
    Ultrasound-Guided Compared With Non-Ultrasound-Guided Placement of Immediate Postpartum Intrauterine Contraceptive Devices.
    Obstet Gynecol. 2022;140:91-93.
    PubMed     Abstract available

  25. EDELMAN AB, Hennebold JD, Bond K, Lim JY, et al
    Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals With Obesity: A Randomized Controlled Trial.
    Obstet Gynecol. 2022;140:48-54.
    PubMed     Abstract available

    June 2022
  26. ROE AH, Abernathy A, Flynn AN, McAllister A, et al
    Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
    Obstet Gynecol. 2022;139:1149-1151.
    PubMed     Abstract available

  27. BIGGS MA, Ehrenreich K, Morris N, Blanchard K, et al
    Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product.
    Obstet Gynecol. 2022;139:1111-1122.
    PubMed     Abstract available

    May 2022
  28. PAKEY J, Nassim JS, Reynolds RV
    Hormonal Intrauterine Devices and Acne.
    Obstet Gynecol. 2022;139:919-921.

  29. PETERSON SF, Lerma K, Shaw KA, Blumenthal PD, et al
    Cervical Preparation Using Ulipristal Acetate With Adjunct Misoprostol in Second-Trimester Surgical Abortions.
    Obstet Gynecol. 2022;139:907-909.

  30. HARMON QE, Patchel SA, Zhao S, Umbach DM, et al
    Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.
    Obstet Gynecol. 2022;139:797-807.
    PubMed     Abstract available

  31. RODRIGUEZ MI, Manibusan B, Kaufman M, McConnell KJ, et al
    Association of Pharmacist Prescription of Contraception With Breaks in Coverage.
    Obstet Gynecol. 2022;139:781-787.
    PubMed     Abstract available

  32. GOLDBERG AB, Fulcher IR, Fortin J, Hofer RK, et al
    Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Obstet Gynecol. 2022;139:771-780.
    PubMed     Abstract available

  33. KOPP-KALLNER H, Linder M, Cesta CE, Segovia Chacon S, et al
    Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy.
    Obstet Gynecol. 2022;139:764-770.
    PubMed     Abstract available

    April 2022
  34. LAZORWITZ A, Pena M, Sheeder J, Teal S, et al
    Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users.
    Obstet Gynecol. 2022;139:579-587.
    PubMed     Abstract available

  35. QURESHEY EJ, Chauhan SP, Wagner SM, Batiste O, et al
    Educational Multimedia Tool Compared With Routine Care for the Uptake of Postpartum Long-Acting Reversible Contraception in Individuals With High-Risk Pregnancies: A Randomized Controlled Trial.
    Obstet Gynecol. 2022;139:571-578.
    PubMed     Abstract available

    March 2022
  36. BRANT AR, Batur P, Arrigain S, Lopez R, et al
    Out-of-Pocket Expenditures for Contraceptives During State Medicaid Expansion, 2013-2016.
    Obstet Gynecol. 2022 Mar 10. pii: 00006250-990000000-00411.

  37. BURGER T, Li J, Zhao Q, Schreiber CA, et al
    Association of Obesity With Longer Time to Pregnancy.
    Obstet Gynecol. 2022 Mar 10. pii: 00006250-990000000-00400.
    PubMed     Abstract available

  38. GARIEPY AM, Lewis C, Zuckerman D, Tancredi DJ, et al
    Patient-Centered Safety Outcomes After Hysteroscopic Compared With Laparoscopic Sterilization.
    Obstet Gynecol. 2022;139:423-432.
    PubMed     Abstract available

  39. DANVERS AA, Evans TA
    Risk of Sterilization Regret and Age: An Analysis of the National Survey of Family Growth, 2015-2019.
    Obstet Gynecol. 2022;139:433-439.
    PubMed     Abstract available

    February 2022
  40. STEENLAND MW, Rodriguez MI, Cohen JL
    Changes in the Supply Duration of Combined Oral Contraception During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2022 Feb 3. pii: 00006250-990000000-00386.

  41. Patient-Centered Contraceptive Counseling: ACOG Committee Statement Number 1.
    Obstet Gynecol. 2022;139:350-353.

    November 2021
  42. MAGNUSSON BM, Christensen SR, Tanner AB, Eyring JB, et al
    Accessibility of Pharmacist-Prescribed Contraceptives in Utah.
    Obstet Gynecol. 2021 Nov 4. pii: 00006250-990000000-00334.
    PubMed     Abstract available

    October 2021
  43. BRANT AR, Kollikonda S, Yao M, Mei L, et al
    Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
    Obstet Gynecol. 2021 Oct 7. pii: 00006250-990000000-00308.
    PubMed     Abstract available

  44. BURLANDO AM, Flynn AN, Gutman S, McAllister A, et al
    The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2021;138:574-577.
    PubMed     Abstract available

    Website Review of Variation in Individual State Medicaid Sterilization Policies.
    Obstet Gynecol. 2021;138:578-579.

  46. BOHN JA, Bullard KA, Rodriguez MI, Ecker AM, et al
    Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2021;138:557-564.
    PubMed     Abstract available

    August 2021
  47. WU JP, Zhang J, McKee M, Akobirshoev I, et al
    Contraceptive Provision and Quality Care Measures for Insured Individuals in Massachusetts Who Are Deaf or Hard of Hearing.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00251.
    PubMed     Abstract available

  48. SCHAUB AM, Pisarska MD, Wright KN
    Intrauterine Adhesions After Chlamydia Infection With a Levonorgestrel-Releasing Intrauterine Device in Place.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00258.
    PubMed     Abstract available

  49. Access to Postabortion Contraception: ACOG Committee Opinion, Number 833.
    Obstet Gynecol. 2021;138:e91-e95.
    PubMed     Abstract available

  50. Access to Postabortion Contraception: ACOG Committee Opinion Summary, Number 833.
    Obstet Gynecol. 2021;138:324-325.
    PubMed     Abstract available

    July 2021
  51. BAKENRA A, Gero A, Sanders J, Simmons R, et al
    Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception.
    Obstet Gynecol. 2021;138:79-84.
    PubMed     Abstract available

  52. ARORA KS, Ponsaran R, Morello L, Katabi L, et al
    Obstetrician-Gynecologists' Practices in Postpartum Sterilization Without a Valid Medicaid Consent Form.
    Obstet Gynecol. 2021;138:66-72.
    PubMed     Abstract available

    June 2021

  53. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
    Obstet Gynecol. 2021;137:e100-e115.
    PubMed     Abstract available

  54. Access to Postpartum Sterilization: ACOG Committee Opinion, Number 827.
    Obstet Gynecol. 2021;137:e169-e176.
    PubMed     Abstract available

    May 2021
  55. HAMDAOUI N, Cardinale C, Fabre C, Baumstarck K, et al
    Pain Associated With Cervical Priming for First-Trimester Surgical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 May 6. pii: 00006250-990000000-00191.
    PubMed     Abstract available

    April 2021
  56. COLEMAN-MINAHAN K, Ela EJ, White K, Grossman D, et al
    Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00175.
    PubMed     Abstract available

  57. ALLANSON ER, Copson S, Spilsbury K, Criddle S, et al
    Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00158.
    PubMed     Abstract available

  58. COHEN M, Edelman A, Bellussi F, Berghella V, et al
    Cochrane Review Summaries-April 2021.
    Obstet Gynecol. 2021;137:747-749.
    PubMed     Abstract available

    March 2021
  59. MEURICE ME, Lovio M, Chang JJ, Perry R, et al
    Contraception Choice Among Those Seeking Abortion for Fetal Indication or Management of Pregnancy Loss.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00125.
    PubMed     Abstract available

  60. BORAAS CM, Sanders JN, Schwarz EB, Thompson I, et al
    Risk of Pregnancy With Levonorgestrel-Releasing Intrauterine System Placement 6-14 Days After Unprotected Sexual Intercourse.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00136.

  61. Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion, Number 823.
    Obstet Gynecol. 2021;137:e75-e88.
    PubMed     Abstract available

    February 2021
    Locating Hormone-Releasing Contraceptive Implants Using Near-Infrared Light.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00117.
    PubMed     Abstract available

  63. ROLAND N, Drouin J, Desplas D, Cuenot F, et al
    Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00100.

    January 2021

  64. Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Undergoing Cancer Treatment: ACOG Committee Opinion, Number 817.
    Obstet Gynecol. 2021;137:e7-e15.
    PubMed     Abstract available

    December 2020
  65. GOLDMAN AR, Porsch L, Hintermeister A, Dragoman M, et al
    Transcutaneous Electrical Nerve Stimulation to Reduce Pain With Medication Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020 Dec 3. doi: 10.1097/AOG.0000000000004208.
    PubMed     Abstract available

    November 2020

  66. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion, Number 813.
    Obstet Gynecol. 2020;136:e90-e99.
    PubMed     Abstract available

  67. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion Summary, Number 813.
    Obstet Gynecol. 2020;136:1072-1073.
    PubMed     Abstract available

    October 2020
  68. FERRIES-ROWE E, Corey E, Archer JS
    Primary Dysmenorrhea: Diagnosis and Therapy.
    Obstet Gynecol. 2020 Oct 8. doi: 10.1097/AOG.0000000000004096.
    PubMed     Abstract available

  69. Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin Summary, Number 225.
    Obstet Gynecol. 2020;136:855-858.
    PubMed     Abstract available

    September 2020
  70. BERKLEY HH, Greene HL, Wittenberger MD
    Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2020 Sep 10. doi: 10.1097/AOG.0000000000004063.
    PubMed     Abstract available

    August 2020
  71. CREININ MD, Grossman DA
    Medication Abortion Up to 70 Days of Gestation.
    Obstet Gynecol. 2020 Aug 12. doi: 10.1097/AOG.0000000000004082.
    PubMed     Abstract available

  72. LEININGER WM, Gupta P
    One Hundred Years of Women's Suffrage: Health Care Advocacy, and Why We Vote.
    Obstet Gynecol. 2020;136:349-353.
    PubMed     Abstract available

    June 2020
  73. SPOTNITZ ME, Natarajan K, Ryan PB, Westhoff CL, et al
    In Reply.
    Obstet Gynecol. 2020;135:1487.

  74. SEL G, Yasar O, Aynali B, Dincer F, et al
    Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
    Obstet Gynecol. 2020;135:1486-1487.

  75. SIMON JA, Al-Hendy A, Archer DF, Barnhart KT, et al
    Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
    Obstet Gynecol. 2020;135:1313-1326.
    PubMed     Abstract available

  76. FLOYD JL, Beasley AD, Swaim LS, Turrentine MA, et al
    Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Obstet Gynecol. 2020;135:1275-1280.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.